Max Meyrath

Research activity per year

Filter

2022
Conolidine analogues as selective ACKR3 modulators for the treatment of cancer and cardiovascular diseases
Chevigne, A. (Inventor), Szpakowska, M. (Inventor), Namjoshi, O. A. (Inventor), Blough, B. E. (Inventor), Decker, A. M. (Inventor) & Meyrath, M. (Inventor), 30 Jun 2022, IPC No. A61K31/397; A61K31/4025; A61K31/404; A61K31/407; A61K31/439; A61K31/4439; A61K31/454; A61K31/496; A61K31/499; A61K31/551; A61P13/12; A61P17/02; A61P25/28; A61P29/00; A61P3/04; A61P31/12; A61P31/18; A61P35/00; A61P37/08; A61P9/00; A61P9/10; C07D401/06; C07D403/06; C07D403/12; C07D471/18; C07D487/04;, Patent No. WO2022136486A1, 22 Dec 2021, Priority date 22 Dec 2020, Priority No. EP20216606A
Research output: Patent
2020
Novel selective ACKR3 modulators and uses thereof
Chevigne, A. (Inventor), Meyrath, M. (Inventor) & Szpakowska, M. (Inventor), 12 Nov 2020, IPC No. A61K38/00; A61K47/62; A61K47/64; A61K48/00; C07K7/08; C12N15/86; G01N33/58, Patent No. WO 2020/225070A1, 30 Apr 2020, Priority date 3 May 2019, Priority No. EP19172560A
Research output: Patent

Open Access

Research output